Home > Drug Search >
  • Targets: Glycoprotein NMB (GPNMB)
  •   > 
Drug Filter
Category:
chemistry (12) biology (3)
Status:
Approved (1) Phase Ⅲ (4) Phase Ⅱ (9) Phase Ⅰ (1)
Clinical Stage:
Pending (1) Active (7) Discontinued (6)
Bio-Type:
Whole antibody (2) ADC (1)
Company:
Dong-A Pharmaceutical (1) Lilly (1) Mitsubishi Tanabe Pharma (1) Pfizer (1) Regeneron Pharmaceutical (1) Sanofi (1) Santen (1) Spectrum Pharmaceuticals (1) Sucampo (1) Takeda (1) Keryx Biopharmaceuticals (1) Unknown (1) Krenitsky Pharmaceutical (1) Celldex (1) vTv Therapeutics (1) Mimetogen Pharmaceuticals (1) Galapagos (1) CeNeRx (1) IXICO (1) Allergan (1)
Indication:
Squamous cell cancer (1) Alzheimer's disease (AD) (4) Amyotrophic lateral sclerosis (ALS) (1) Anemia (1) Breast cancer (1) Chemotherapy-induced peripheral neuropathy (1) Diabetic nephropathy (2) Dry eye disease (1) Hepatic disorders (1) Melanoma (1) Osteosarcoma (1) Parkinson's disease (PD) (2) Rheumatoid arthritis (RA) (1) Corneal epithelial defects (1) Pain (2) Spinal cord injury (1) Diabetic neuropathy (1) Neurological disease (1) Cardiovascular disorders (1) Skin disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top